









Mercado
/
Acciones
/
nasdaq-apdn
/

Applied DNA Sciences Inc

APDN

5.620USD

0.000

Cierre 11/04, 16:00（ET）Cotizaciones retrasadas 15 min

5.07MCap. mercado

PérdidaP/E TTM



Applied DNA Sciences Inc

5.620

0.000

Descripción general Compañía Finanzas Análisis

Descripción general

Compañía

Finanzas

Análisis

Más Datos de Applied DNA Sciences Inc Compañía

Applied DNA Sciences, Inc. is a biotechnology company. The Company is engaged in developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The Company operates through three segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. Therapeutic DNA Production Services segment operations consist of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of messenger RNA (mRNA) therapeutics. MDx Testing Service segment operations consist of performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. DNA Tagging and Security Products and Services segment operations consist of the manufacture and detection of DNA for industrial supply chains and security services.

Información de Applied DNA Sciences Inc



Símbolo de cotizaciónAPDN

Nombre de la empresaApplied DNA Sciences Inc

Fecha de salida a bolsaAug 24, 2001

Director ejecutivoMs. Judith Murrah

Número de empleados46

Tipo de seguridadOrdinary Share

Fin del año fiscalAug 24

Dirección50 Health Sciences Drive

CiudadSTONY BROOK

Bolsa de valoresNASDAQ Capital Market Consolidated

PaísUnited States of America

Código postal11790

Teléfono16312408800

Sitio Webhttps://adnas.com/

Símbolo de cotizaciónAPDN

Fecha de salida a bolsaAug 24, 2001

Director ejecutivoMs. Judith Murrah

Ejecutivos de Applied DNA Sciences Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Clay Shorrock, J.D.

Chief Executive Officer

18.70K

+467275.00%

Ms. Beth M. Jantzen

Chief Financial Officer

18.69K

+623033.33%

Mr. Robert B. (Bob) Catell

Independent Director

1.00

Mr. Joseph D. Ceccoli

Independent Director

1.00

Ms. Judith Murrah

Chairman of the Board

1.00

-66.67%

Dr. Yacov A. Shamash, Ph.D.

Independent Director

1.00

Ms. Elizabeth M. Schmalz Shaheen

Independent Director

Mr. Sanjay M. Hurry

Executive Director - Investor Relations and Corporate Communications

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Clay Shorrock, J.D.

Chief Executive Officer

18.70K

+467275.00%

Ms. Beth M. Jantzen

Chief Financial Officer

18.69K

+623033.33%

Mr. Robert B. (Bob) Catell

Independent Director

1.00

Mr. Joseph D. Ceccoli

Independent Director

1.00

Ms. Judith Murrah

Chairman of the Board

1.00

-66.67%

Dr. Yacov A. Shamash, Ph.D.

Independent Director

1.00

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de oct

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Product and authentication services - Large scale DNA production

161.00K

52.89%

Product and authentication services - Supply chain

91.32K

30.00%

Research and development services

52.07K

17.11%

Sin datos

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Product and authentication services - Large scale DNA production

161.00K

52.89%

Product and authentication services - Supply chain

91.32K

30.00%

Research and development services

52.07K

17.11%

Estadísticas de accionistas

Actualizado: lun., 3 de nov

Accionistas

Tipos de accionistas

Accionistas

Proporción

Anson Funds Management LP.

0.79%

Sabby Management, LLC

0.41%

Jantzen (Beth M)

0.32%

Shorrock (Clay)

0.32%

UBS Financial Services, Inc.

0.19%

Otro

97.98%

Accionistas

Proporción

Anson Funds Management LP.

0.79%

Sabby Management, LLC

0.41%

Jantzen (Beth M)

0.32%

Shorrock (Clay)

0.32%

UBS Financial Services, Inc.

0.19%

Otro

97.98%

Tipos de accionistas

Accionistas

Proporción

Hedge Fund

0.79%

Individual Investor

0.63%

Investment Advisor/Hedge Fund

0.41%

Investment Advisor

0.19%

Corporation

0.16%

Otro

97.82%

Participación institucional



Actualizado: mié., 1 de oct

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2025Q3

89.41K

1.51%

+65.56K

2025Q2

34.98K

6.73%

-8.84K

2025Q1

45.20K

34.86%

+11.50K

2024Q4

25.60M

46.39%

+1.44M

2024Q3

1.08M

9.78%

+703.30K

2024Q2

1.19M

10.83%

+424.27K

2024Q1

243.32K

209.10%

+86.27K

2023Q4

96.98K

13.46%

-84.74K

2023Q3

149.12K

21.28%

-82.31K

2023Q2

142.47K

21.43%

-74.27K

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

Anson Funds Management LP.

46.51K

3.6%

+41.94K

+918.33%

Jun 30, 2025

Sabby Management, LLC

24.36K

1.89%

+17.39K

+249.63%

Jun 30, 2025

Jantzen (Beth M)

3.00

Apr 03, 2025

Shorrock (Clay)

4.00

Apr 03, 2025

UBS Financial Services, Inc.

11.13K

0.86%

+8.82K

+381.65%

Jun 30, 2025

UBS Switzerland AG

493.00

0.04%

+493.00

Jun 30, 2025

Tower Research Capital LLC

222.00

0.02%

+190.00

+593.75%

Jun 30, 2025

SBI Securities Co., Ltd.

146.00

0.01%

+79.00

+117.91%

Jun 30, 2025

Grossman (Bruce)

111.00

0.01%

+111.00

Feb 02, 2024

Sanctuary Advisors, LLC

20.00

+20.00

Dec 31, 2024

ETFs relacionados



Nombre

Proporción

Sin datos

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Tipo

Relación

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Apr 22, 2024

Merger

20→1

Apr 22, 2024

Merger

20→1

Fecha

Tipo

Relación

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Mar 12, 2025

Merger

50→1

Apr 22, 2024

Merger

20→1

Apr 22, 2024

Merger

20→1

Apr 22, 2024

Merger

20→1

Apr 22, 2024

Merger

20→1

KeyAI

